Bath Savings Trust Co Sells 1,553 Shares of Balchem Co. (NASDAQ:BCPC)

Bath Savings Trust Co lowered its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 4.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,049 shares of the basic materials company's stock after selling 1,553 shares during the quarter. Bath Savings Trust Co owned 0.10% of Balchem worth $5,320,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of BCPC. Versant Capital Management Inc lifted its position in shares of Balchem by 534.2% during the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock valued at $40,000 after acquiring an additional 203 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Balchem by 2.2% during the fourth quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company's stock valued at $626,000 after purchasing an additional 84 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new stake in shares of Balchem during the fourth quarter valued at $3,246,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Balchem by 9.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 91,742 shares of the basic materials company's stock valued at $14,953,000 after purchasing an additional 8,091 shares during the period. Finally, Voloridge Investment Management LLC raised its holdings in Balchem by 41.0% during the 4th quarter. Voloridge Investment Management LLC now owns 26,178 shares of the basic materials company's stock worth $4,267,000 after buying an additional 7,608 shares during the period. 87.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Wall Street Zen cut shares of Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Sidoti raised shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. Finally, HC Wainwright set a $180.00 target price on Balchem and gave the company a "buy" rating in a report on Monday, April 28th.

Balchem Stock Down 0.0%

Shares of BCPC traded down $0.08 during trading hours on Friday, reaching $166.10. The company's stock had a trading volume of 153,968 shares, compared to its average volume of 138,521. The company has a 50 day moving average of $162.12 and a two-hundred day moving average of $165.74. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The firm has a market cap of $5.42 billion, a price-to-earnings ratio of 42.26, a P/E/G ratio of 4.41 and a beta of 0.93. Balchem Co. has a 1-year low of $145.70 and a 1-year high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last issued its earnings results on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $250.52 million during the quarter, compared to analysts' expectations of $245.70 million. During the same quarter last year, the firm earned $1.03 EPS. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. As a group, research analysts predict that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.